黑色素瘤分泌的黑色素体-MHC I 破坏T细胞抗瘤免疫力
1Department of Immunology, Center for Immunotherapy, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Trends in cancer
|February 27, 2026
概括
黑色素瘤细胞通过主要基因相容性复合物I类 (MHC I) 分子在黑色素体上输出瘤抗原. 这些分泌的MHC I诱会损害细胞毒性CD8+ T细胞检测和破坏癌细胞的能力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 主体组织相容性复合物I类 (MHC I) 分子对于向CD8+ T细胞呈现瘤抗原至关重要,从而启动抗瘤免疫反应.
- 黑色素瘤是一种皮肤癌,它采用各种策略来逃避免疫系统.
研究的目的:
- 为了阐明黑色素瘤利用的新型免疫逃避机制.
- 为了研究分泌的黑色素体在免疫逃避中的作用.
主要方法:
- 这项研究涉及分析黑色素瘤细胞分泌的黑色素体的含量和功能.
- 研究了分泌的黑色素体和细胞毒性CD8+ T细胞之间的相互作用.
主要成果:
- 发现黑色素瘤细胞在分泌的黑色素体上输出带有的MHC I分子.
- 这些分泌的MHC I-复合体作为诱,有效地混和抑制细胞毒性CD8+T细胞活性.
- 这种机制代表了黑色素瘤破坏抗瘤免疫监测的新方法.
结论:
- 在黑色素体上输出MHC I是一种复杂的免疫逃避策略,用于黑色素瘤.
- 准这种机制可能为增强黑色素瘤患者抗瘤免疫力提供新的治疗途径.
相关概念视频
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Antigens Involved in Adaptive Immunity
1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K


